<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000556428">
  <TermName>tetra-O-methyl NDGA</TermName>
  <TermPronunciation>(TEH-truh-O-MEH-thul ...)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It blocks proteins needed for cancer growth. It is a type of transcriptional inhibitor. Also called EM-1421 and tetra-O-methyl nordihydroguaiaretic acid.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000721041" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tetra-O-methyl NDGA&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000721042" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ácido NDGA tetra-O-metilo&quot;" language="es" id="_4"/>
  <SpanishTermName>ácido NDGA tetra-O-metilo</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Bloquea las proteínas que el cáncer necesita para crecer. Es un tipo de inhibidor de la transcripción. También se llama ácido nordihidroguaiarético tetra-O-metilo y EM-1421.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-06-21</DateFirstPublished>
</GlossaryTerm>
